Radon is the second leading cause of lung cancer and testing the home for this radioactive gas is essential.
Illumina and IBM team up to create a standardized gene sequencing process to help in cancer research.
A breakthrough blood test could predict the risk of dying from diseases like cancer, heart disease and diabetes.
A team of scientists discovered a key genetic driver for a rare type of breast cancer, metaplastic breast cancer.
The cancer death rate in the United States dropped by a staggering 25 percent in the past 25 years.
Scientists may have the solution to the growing cases of aggressive melanoma, the deadliest type of skin cancer.
Researchers have created a new immune vaccine intended to fight and kill breast cancer cells.
A 29-year-old woman battling Hodgkin's lymphoma gave birth to quadruplets they conceived naturally.
Researchers found a new way to highlight to detect and remove cancerous cells without affecting the healthy cells by using an optical fiber probe.
Glioblastoma Multiforme, the deadliest type of brain cancer, is very hard to treat because of its resistance to treatment. Now, a new treatment has been found by scientists.
Cancer has taken a toll on the lives of millions of people worldwide. Now, vitamin C has been linked to the prevention and battle of cancer.
Why is cancer difficult to treat? A team of scientists may have the answer.
This New Year, many people would vow to quit smoking. There are many ways to successfully quit smoking tobacco and quitlines can help.
A breakthrough study used a common virus, the reovirus, which causes respiratory infection among children. Once harnessed in its benign form, the virus can be used as an agent of immunotherapy to treat liver cancer caused by HCV.
The doctors harvested immune cells from the blood of the patient and using CRISPR disabled that protein PD-1, which have been known to help cancer cells grow. These cells were multiplied and injected back to the patient, hoping that the edited cells will stop the lung cancer from further advancing. The Chinese trial is the first time that CRISPR was used as a cancer cure and in treating live human patients.